[1]季雅楠,田春燕,郭丹丹,等.基于PI3K/Akt信号通路探讨中医药治疗支气管哮喘研究进展[J].陕西中医,2023,(12):1827-1830.[doi:DOI:10.3969/j.issn.1000-7369.2023.12.036]
　JI Yanan,TIAN Chunyan,GUO Dandan,et al.Progress in the treatment of bronchial asthma with traditional Chinese medicine based on PI3K/Akt signaling pathway[J].,2023,(12):1827-1830.[doi:DOI:10.3969/j.issn.1000-7369.2023.12.036]
点击复制

基于PI3K/Akt信号通路探讨中医药治疗支气管哮喘研究进展
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2023年12期
页码:
1827-1830
栏目:
综 述
出版日期:
2023-12-05

文章信息/Info

Title:
Progress in the treatment of bronchial asthma with traditional Chinese medicine based on PI3K/Akt signaling pathway
作者:
季雅楠1; 田春燕2; 郭丹丹1; 李竹英2
(1.黑龙江中医药大学,黑龙江 哈尔滨 150040; 2.黑龙江中医药大学附属第一医院,黑龙江 哈尔滨 150040)
Author(s):
JI Yanan; TIAN Chunyan; GUO Dandan; LI Zhuying
(Heilongjiang University of Traditional Chinese Medicine,Harbin 150040,China)
关键词:
支气管哮喘;  信号通路;  PI3K/Akt;  气道炎症;  气道重塑;  细胞自噬
Keywords:
Bronchial asthma;  Signal pathway;  PI3K/Akt;  Airway inflammation;  Airway remodeling;  Cell autophagy
分类号:
R 562.2
DOI:
DOI:10.3969/j.issn.1000-7369.2023.12.036
文献标志码:
A
摘要:
支气管哮喘是一种常见和多发的慢性呼吸道炎性疾病。随着哮喘发病机制和细胞信号转导的深入研究,PI3K/Akt信号通路在哮喘发生发展的重要作用日益受到重视,与哮喘气道炎症、气道重塑、细胞自噬等密切相关。中医药治疗哮喘的经验丰富,临床疗效较好。近年研究表明,中医药治疗哮喘的作用机制可能与PI3K/Akt信号通路有关,中药单体、中药复方、中医外治法等可以通过调控PI3K/Akt信号通路减轻气道炎症、抗气道重塑及抑制自噬,从而有效改善哮喘症状,发挥防治作用。系统综述了PI3K/Akt信号通路的结构组成、与哮喘的关系、中医药干预PI3K/Akt信号通路的研究进展,以期为哮喘的临床治疗提供参考。
Abstract:
Bronchial asthma is a common and frequent chronic respiratory inflammatory disease.With the in-depth research on the pathogenesis of asthma and cell signal transduction,the important role of PI3K/Akt signaling pathway in the occurrence and development of asthma is increasingly being valued,closely related to asthma airway inflammation,airway remodeling and cell autophagy.TCM has rich experience in treating asthma and its clinical effect has been recognized.Recent studies have shown that the mechanism of TCM in treating asthma may be related to PI3K/Akt signaling pathway.TCM monomers,herbal formulas and external treatment methods can alleviate airway inflammation,resist airway remodeling,and inhibit autophagy by regulating the PI3K/Akt signaling pathway,thereby effectively improving asthma symptoms,exerting preventive and therapeutic effects.This article systematically reviews the structure and composition of PI3K/Akt signaling pathway,its relationship with asthma,and the research progress of TCM intervention in PI3K/Akt signaling pathway,in order to provide reference for the scientific research and treatment of asthma.

参考文献/References:

[1] 宋 鑫,魏 巍,郑靖玉,等.玉屏风颗粒联合沙丁胺醇及布地奈德治疗哮喘急性发作的临床观察[J].实用中西医结合临床,2022,22(24):9-11,108.
[2] 傅相均,庹芳旭,唐 寅,等.PI3K/Akt信号通路在环境内分泌干扰物影响哮喘发作中的作用[J].实用医学杂志,2018,34(6):1030-1031.
[3] Fruman DA,Rommel C.PI3K and cancer:Lessons,challenges and opportunities[J].Nature Reviews Drug Discovery,2014,13(2):140-143.
[4] Durrant TN,Hers I.PI3K inhibitors in thrombosis and cardiovascular disease[J].Clinical and Translational Medicine,2020,9(1):8.
[5] Xu F,Na L,Li Y,et al.Roles of the PI3K/AKT/mTOR signalling pathways in neurodegenerative diseases and tumours[J].Cell and Bioscience,2020,10(1):57.
[6] 郑靓怡,胡黄金,杨 妮,等.基于PI3K/AKT通路研究升降通癃方对前列腺增生细胞的影响[J].陕西中医,2023,44(5):566-570.
[7] Jeong JS,Kim JS,Kim SR,et al.Defining bronchial asthma with phosphoinositide 3-kinase delta activation:Towards endotype-driven management[J].International Journal of Molecular Sciences,2019,20(14):3525-3527.
[8] Huang L,Wang M,Yan Y,et al.OX40L induces helper T cell differentiation during cell immunity of asthma through PI3K/AKT and P38 MAPK signaling pathway[J].Journal of Translational Medicine,2018,16(1):78-81.
[9] 康文玥,杨淑梅,遆嬿羽,等.嗜酸性粒细胞与慢性阻塞性肺疾病相关性研究进展[J].陕西医学杂志,2021,50(8):1034-1037.
[10] 刘红红,邢宁宁,师丽敏,等.支气管哮喘患者气道炎症与EOS的PI3K/Akt信号通路活化程度的关系研究[J].河北医科大学学报,2021,42(8):881-885.
[11] Stephen GW,Peter F.Isoform-specific phosphoinositide 3-kinase inhibitors as therapeutic agents[J].Current Opinion in Pharmacology,2003,3(4):426-434.
[12] Liu LL,Li FH,Zhang Y,et al.Tangeretin has anti-asthmatic effects via regulating PI3K and notch signaling and modulating Th1/Th2/Th17 cytokine balance in neonatal asthmatic mice[J].Brazilian Journal of Medical and Biological Research,2017,50(8):5991.
[13] 庞亚蓉,席建宏,王志旺,等.磷脂酰肌醇3激酶/蛋白激酶B(PI3K/Akt)信号通路参与哮喘气道炎症反应的研究现状[J].中国临床药理学杂志,2021,37(14):1899-1900.
[14] 刘 健,王佳丽,曹慧丹,等.补肺颗粒对哮喘小鼠气道重塑的影响及机制研究[J].陕西中医,2022,43(5):559-563.
[15] 潘凌宇,韩燕全,柳 清,等.气道重塑与磷脂酰肌醇3激酶/蛋白激酶B信号通路在支气管哮喘发病机制中的研究进展[J].安徽医药,2016,20(12):2216.
[16] Wang J,Li F,Yang M,et al.FIZZ1 promotes airway remodeling through the PI3K/Akt signaling pathway in asthma[J].Experimental and Therapeutic Medicine,2014,7(5):1265-1270.
[17] 陈玉梅,童 瑾.气道黏液高分泌机制的研究进展[J].基础医学与临床,2016,36(11):1573-1577.
[18] Huang P,Li Y,Lyu Z,et al.Comprehensive attenuation of IL-25-induced airway hyperresponsiveness,inflammation and remodelling by the PI3K inhibitor LY294002[J].Respirology,2017,22(1):78-85.
[19] 杜旭升,李东繁.PM2.5对小鼠肺部自噬、核因子相关因子2、核因子κB表达影响实验研究[J].陕西医学杂志,2020,49(4):397-400,410.
[20] 陈延斌,黄建安.自噬在呼吸系统的研究现状[J].中国呼吸与危重监护杂志,2017,16(6):631.
[21] 孙 鹏,张 倩.细胞自噬和支气管哮喘[J].南京医科大学学报:自然科学版,2021,41(5):780-782.
[22] 蒋鹏娜.基于PI3K/Akt信号通路探讨平喘颗粒干预气道上皮细胞自噬与凋亡的机制[D].哈尔滨:黑龙江中医药大学,2018.
[23] 何显科,韦锦斌,陈伟杰.龙脷叶总黄酮干预对OVA诱导的哮喘大鼠肺内炎性浸润、氧化应激的影响及机制探究[J].广西医科大学学报,2022,39(7):1080-1085.
[24] 刘 楠,李 纳,朱 琳,等.和厚朴酚通过PI3K/Akt信号通路对哮喘小鼠的作用及其对TLR2、TLR4表达的影响[J].中草药,2019,50(6):1407-1412.
[25] Tan SS,Ong B,Cheng C,et al.The antimalarial drug artesunate inhibits primary human cultured airway smooth muscle cell proliferation[J].American Journal of Respiratory Cell and Molecular Biology,2014,50(2):451.
[26] 咸哲民,王重阳,朴玉华,等.欧前胡素通过TGF-β1/Smad3和PI3K/Akt信号通路对哮喘小鼠气道重塑模型的影响[J].中国药理学通报,2018,34(12):1719-1724.
[27] 江立斌,戴金峰.穿山龙总皂苷对哮喘小鼠BRP-39表达及PI3K/AKT信号通路的影响[J].中国中西医结合杂志,2020,40(1):75-79.
[28] 冯晓纯,陈琼芳,洪天一,等.蝎黄解痉治哮颗粒对支气管哮喘模型小鼠肺组织PI3K/AKT通路的影响[J].中医杂志,2021,62(8):717-721.
[29] 李明明,屈 彬,方向明.平喘宁调节PI3K/Akt信号通路干预寒性哮喘大鼠气道重塑的机制[J].云南中医学院学报,2019,42(2):11-15.
[30] 李明明.平喘宁调节PI3K-Akt/PKB信号通路相关蛋白p110、PTEN、PIP3、GSK3、PDK1干预哮喘大鼠气道重塑机制的研究[D].合肥:安徽中医药大学,2020.
[31] 孟 芝,方向明.平喘宁对寒性哮喘大鼠PI3K/Akt信号通路相关信号分子表达的影响[J].安徽中医药大学学报,2019,38(3):72-76.
[32] 李竹英,田春燕,蒋鹏娜,等.基于PI3K/Akt/mTOR信号通路探讨平喘颗粒对气道上皮细胞自噬的作用机制[J].中华中医药杂志,2019,34(11):5094-5098.
[33] 蒋鹏娜,张佩青,王丽洁.平喘颗粒对气道高反应大鼠气道重塑的干预作用研究[J].广西医科大学学报,2021,38(8):1528-1533.
[34] 汝触会,何 飞,郑 琦,等.基于PI3K/Akt信号通路探讨芍药甘草汤对哮喘大鼠Treg细胞的作用[J].中国中医药科技,2020,27(6):862-865.
[35] 杨金华,赵 叶,李 双,等.针刺对支气管哮喘大鼠肺组织PI3K蛋白表达的影响[J].中国中医基础医学杂志,2017,23(11):1602-1604,1614.
[36] 赵桓艺.基于PI3K/AKT探讨针刺调控内质网应激-自噬对哮喘炎症及T细胞亚群的影响[D].广州:广州中医药大学,2021.
[37] 乔 赟,雷惠婷,易 蔚,等.基于PI3K信号通路探讨肺“俞募配穴”艾炷灸对哮喘小鼠RORγt/Foxp3表达的影响[J].针刺研究,2021,46(4):272-277.

相似文献/References:

[1]吕明辉,贾艳平,元国红.清热涤痰定喘汤联合穴位贴敷治疗儿童支气管哮喘安全性及疗效分析[J].陕西中医,2019,(1):25.
　LV Minghui,JIA Yanping,YUAN Guohong..Safety and efficacy of Qingre Ditan Dingchuan decoction combined with acupoint sticking in the treatment of bronchial asthma in children[J].,2019,(12):25.
[2]李红芬,毕玲莉,张茂华.小青龙汤联合糖皮质激素对支气管哮喘患儿气道重塑 及相关炎症因子的影响[J].陕西中医,2019,(5):631.
　LI Hongfen,BI Lingli,ZHANG Maohua..Effects of Xiaoqinglong decoction combined with glucocorticoid on airway remodeling and related inflammatory factors in children with bronchial asthma[J].,2019,(12):631.
[3]唐徐韵,陈盼碧△.穴位埋线治疗支气管哮喘的实验研究探讨*[J].陕西中医,2019,(12):1789.
[4]温利娟,薛晓鸥△,马秀丽,等.紫柏凝胶通过调节ERK及P38/MAPK信号通路下调宫颈癌荷瘤裸鼠E6、E7蛋白表达研究*[J].陕西中医,2020,(5):589.[doi:DOI:10.3969/j.issn.10007369.2020.05.010]
　WEN Lijuan,XUE Xiao'ou,MA Xiuli,et al.Zibai gel down-regulate E6,E7 protein expression in cervical cancer-bearing nude mice by regulating ERK and P38/MAPK signal pathways[J].,2020,(12):589.[doi:DOI:10.3969/j.issn.10007369.2020.05.010]
[5]冷 静,王艳梅,李 慧△.理肺化瘀方治疗支气管哮喘疗效及对患者血清内IgG、IgA、IgM的变化研究*[J].陕西中医,2020,(5):618.[doi:DOI:10.3969/j.issn.10007369.2020.05.018]
　LENG Jing,WANG YanMei,LI Hui..Lifei Huayu decoction in the treatment of bronchial asthma and the change of serum IgG,IgA,IgM in patients[J].,2020,(12):618.[doi:DOI:10.3969/j.issn.10007369.2020.05.018]
[6]李 超,宋 伟,彭 冰,等.养阴清热化瘀方对急性放射性肺炎大鼠TLR-4/NF-κB信号通路的影响*[J].陕西中医,2020,(7):864.[doi:DOI:10.3969/j.issn.10007369.2020.07.007]
　LI Chao,SONG Wei,PENG Bing,et al.Effect of Yangyin Qingre Huayu recipe on signal pathway of TLR-4/NF-κB in rats with acute radiation pneumonia[J].,2020,(12):864.[doi:DOI:10.3969/j.issn.10007369.2020.07.007]
[7]杜 婧,王少兰,韩 曼,等.孕烷X受体与炎症反应及中药干预机制研究进展*[J].陕西中医,2020,(11):1673.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.041]
　DU Jing,WANG Shaolan,HAN Man,et al.Advances in studies on progesterone X receptor,inflammatory response and intervention mechanism of traditional Chinese medicine[J].,2020,(12):1673.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.041]
[8]权浩浩,程小红,杜 霞,等.基于整合药理学探讨肾复康Ⅱ号胶囊治疗肾间质纤维化作用机制*[J].陕西中医,2020,(12):1822.[doi:DOI:10.3969/j.issn.1000-7369.2020.12.038]
[9]王兰香,李卫红,周 瑾,等.消积豁痰汤加减联合糖皮质激素治疗老年支气管哮喘临床研究[J].陕西中医,2021,(6):724.[doi:DOI:10.3969/j.issn.1000-7369.2020.06.011]
[10]仝建松.基于Janus激酶2/信号转导和转录激活因子3信号通路探讨参苓白术散对溃疡性结肠炎模型大鼠炎症抑制作用研究[J].陕西中医,2021,(8):1010.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.006]
　TONG Jiansong.Study on the inhibitory effect of Shenling Baizhu powder on inflammation of ulcerative colitis model rats based on Janus kinase 2/signal transduction and transcription activator 3 signaling pathway[J].,2021,(12):1010.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.006]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金资助面上项目(82074365,82274420); 黑龙江省第二批省级名中医专家传承工作室建设项目[(2021)24号]; 黑龙江省级领军人才梯队后备带头人项目[(2021)296号]
更新日期/Last Update: 2023-12-08